Key Statistics for 600518
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (CNY) (ttm)
|Est. EPS (CNY) (12/2013)
|Est. PEG Ratio
|Market Cap (M CNY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (CNY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 600518
- Net Income (M/CNY)
Kangmei Pharmaceutical Co., Ltd. develops, produces, and sells medicines that are used for the treatment of high blood pressure and cold. The Company also pr oduces antibiotic drugs and health care products. Kangmei also sells other manufacturers' medical products through its wholesale and retail chain.
More Company Profile & Key Executives for 600518
|Ma XingtianChairman/President||Xu DongjinVice Chairman/VP|
|Lin GuoxiongVice President||Qiu XiweiVP/Secretary|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries